Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000201:enzymology; D006246:Harmaline / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D009206:Myocardium / Q000201:enzymology; D010293:Pargyline / Q000494:pharmacology*; D010627:Phenethylamines / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013379:Substrate Specificity
D000470:Alkaloids; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D012701:Serotonin; D010293:Pargyline; D006246:Harmaline